From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Tom Winnifrith Bearcast: happy anniversary, Forward Partners. Not! And so much pride in Joshua ahead of sports day

By Tom Winnifrith | Monday 20 June 2022


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


He might come home with a raft of certificates for "Welsh speaker of the week", or other such academic achievements, but Joshua is no great sportsman. Yet this afternoon, it is the school sports day, and the whole family is off to watch him. Discussing what lies ahead with him as we walked to school this morning, filled me with pride. In the main podcast, I look at Forward Partners (FWD) - another disastrous 2021 IPO; Petropavlovsk (POG), as it races to zero; Genflow Biosciences (GENF); MGC Pharmaceuticals (MXC) - placing ahoy; and Verditek (VDTK), where things could get very messy within days. Ref MXC, I discuss two historic examples of biotech's presenting data - on AIDS "cures", and its spoof ramp last week.

You must be a paid subscriber to listen to Bearcast
ShareProphets is reader-supported journalism

Join us for free and gain access to three articles per month

Or become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

AAU

Gold up Ariana down

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

Time left: 07:20:26